🇺🇸 FDA
Pipeline program

Matching placebo for Survodutide, BI 456906, BI 456906, BI 456906, BI 456906, BI 456906

22774

Phase 2 small_molecule active

Quick answer

Matching placebo for Survodutide, BI 456906, BI 456906, BI 456906, BI 456906, BI 456906 for Chronic Kidney Disease is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Chronic Kidney Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials